PMS-OLANZAPINE ODT 5 MG — DIN 02303191
OLANZAPINE : 5 MG · PHARMASCIENCE INC · TABLET (ORALLY DISINTEGRATING) · wholesale supply in Canada
Health Canada status: MARKETED
What is PMS-OLANZAPINE ODT?
PMS-OLANZAPINE ODT 5 MG contains OLANZAPINE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02303191, held by PHARMASCIENCE INC, supplied as TABLET (ORALLY DISINTEGRATING) for ORAL administration. Health Canada currently lists it as marketed, status dated 15-Oct-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PMS-OLANZAPINE ODT used for?
pms - OLANZAPINE or pms - OLANZAPINE ODT (olanzapine) is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders. Olanzapine is also indicated for the acute treatment of manic or mixed episodes in bipolar I disorder, and may be used as monotherapy or co-therapy with agents commonly used in the treatment of acute bipolar disorder.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Olanzapine cost around the world?
Olanzapine is listed on 13 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Bahrain publishes a retail (max). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Austria | KVP (Kassenverkaufspreis) | 58 | 111 | EUR███.██ |
| Greece | producer price (ex-factory) | 107 | 107 | EUR███.██ |
| United States | acquisition | 7 | 102 | USD███.██ |
| Czechia | max producer price (ex-factory) | 13 | 67 | CZK███.██ |
| South Africa | single exit price | 59 | 65 | ZAR███.██ |
| Australia | ex-manufacturer | 20 | 53 | AUD███.██ |
| Saudi Arabia | public | 37 | 41 | SAR███.██ |
| Hungary | producer price (ex-factory) | 17 | 17 | HUF███.██ |
| Morocco | PPV (public price) | 5 | 17 | MAD███.██ |
| Bahrain | retail (max) | 6 | 15 | BHD███.██ |
| Luxembourg | reimbursement | 13 | 13 | EUR███.██ |
| United Arab Emirates | public | 9 | 10 | AED███.██ |
| United Kingdom | hospital | 10 | 10 | GBP███.██ |
628 pack listings across 361 brand entries and 11 price bases, refreshed 08 Sep 2026. Ranges span every Olanzapine pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Olanzapine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
32 holders have a Canadian DIN containing Olanzapine, across 271 DINs, of which 103 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| CHEPLAPHARM REGISTRATION GMBH | 11 | 11 | ZYPREXA, ZYPREXA INTRAMUSCULAR, ZYPREXA ZYDIS | Sourceable in Canada |
| APOTEX INC | 10 | 10 | APO-OLANZAPINE, APO-OLANZAPINE ODT | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 10 | 10 | JAMP OLANZAPINE FC, JAMP OLANZAPINE ODT | Sourceable in Canada |
| NORA PHARMA INC | 10 | 10 | NRA-OLANZAPINE, NRA-OLANZAPINE ODT | Sourceable in Canada |
| PRO DOC LIMITEE | 10 | 10 | OLANZAPINE, OLANZAPINE ODT | Sourceable in Canada |
| SIVEM PHARMACEUTICALS ULC | 10 | 10 | OLANZAPINE, OLANZAPINE ODT | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 12 | 9 | OLANZAPINE FOR INJECTION, SANDOZ OLANZAPINE, SANDOZ OLANZAPINE ODT | Sourceable in Canada |
| PHARMASCIENCE INC | 10 | 8 | PMS-OLANZAPINE, PMS-OLANZAPINE ODT | Sourceable in Canada |
| SANIS HEALTH INC | 9 | 8 | OLANZAPINE, OLANZAPINE ODT | Sourceable in Canada |
| MINT PHARMACEUTICALS INC | 9 | 7 | MINT-OLANZAPINE, MINT-OLANZAPINE ODT | Sourceable in Canada |
| TEVA CANADA LIMITED | 19 | 6 | ACT OLANZAPINE ODT, NTP-OLANZAPINE, TEVA-OLANZAPINE, TEVA-OLANZAPINE OD, TEVA-OLANZAPINE ODT | Sourceable in Canada |
| AURO PHARMA INC | 4 | 4 | AURO-OLANZAPINE ODT | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 5 MG |
|---|---|
| Dosage form | TABLET (ORALLY DISINTEGRATING) |
| Route | ORAL |
| Pack configuration (monograph) | null |
| Storage | null |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Olanzapine |
|---|---|
| ATC code | N05AH03 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02303191 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2303191 |
| Brand name | PMS-OLANZAPINE ODT |
| Generic / active ingredient | OLANZAPINE : 5 MG |
| Market authorization holder | PHARMASCIENCE INC |
| Health Canada schedule | Prescription |
| ATC code | N05AH03 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05AH |
| Current status | MARKETED |
| Status date | 15-Oct-2009 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Olanzapine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
103 of 271 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-OLANZAPINE | 2.5 MG | TABLET | APOTEX INC | MARKETED | 02281791 |
| APO-OLANZAPINE | 10 MG | TABLET | APOTEX INC | MARKETED | 02281821 |
| APO-OLANZAPINE | 20 MG | TABLET | APOTEX INC | MARKETED | 02333015 |
| APO-OLANZAPINE | 15 MG | TABLET | APOTEX INC | MARKETED | 02281848 |
| APO-OLANZAPINE | 5 MG | TABLET | APOTEX INC | MARKETED | 02281805 |
| APO-OLANZAPINE | 7.5 MG | TABLET | APOTEX INC | MARKETED | 02281813 |
| APO-OLANZAPINE ODT | 10 MG | TABLET (ORALLY DISINTEGRATING) | APOTEX INC | MARKETED | 02360624 |
| APO-OLANZAPINE ODT | 15 MG | TABLET (ORALLY DISINTEGRATING) | APOTEX INC | MARKETED | 02360632 |
| APO-OLANZAPINE ODT | 5 MG | TABLET (ORALLY DISINTEGRATING) | APOTEX INC | MARKETED | 02360616 |
| APO-OLANZAPINE ODT | 20 MG | TABLET (ORALLY DISINTEGRATING) | APOTEX INC | MARKETED | 02360640 |
2 · Same class — other molecules in ATC N05AH
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Olanzapine | ABBOTT-OLANZAPINE ODT · ACCEL-OLANZAPINE · ACT OLANZAPINE · ACT OLANZAPINE ODT · +46 more | 271 | 103 | Yes |
| Quetiapine | ABBOTT-QUETIAPINE · ACCEL-QUETIAPINE · ACH-QUETIAPINE · ACH-QUETIAPINE FUMARATE XR · +43 more | 236 | 93 | Yes |
| Clozapine | AA-CLOZAPINE · AURO-CLOZAPINE · CLOZAPINE TABLETS · CLOZARIL · +3 more | 28 | 17 | Yes |
| Loxapine | APO-LOXAPINE · DOM-LOXAPINE TABLETS 10MG · DOM-LOXAPINE TABLETS 25MG · DOM-LOXAPINE TABLETS 50MG · +27 more | 51 | 4 | Yes |
| Asenapine | MINT-OLANZAPINE ODT · SAPHRIS | 3 | 3 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05AX | Aripiprazole · Brexpiprazole · Cariprazine · Paliperidone · Risperidone | 352 | 175 |
| N05AE | Lurasidone · Ziprasidone | 60 | 41 |
| N05AB | Fluphenazine · Perphenazine · Prochlorperazine · Thioproperazine · Trifluoperazine | 104 | 10 |
| N05AD | Droperidol · Haloperidol | 53 | 9 |
| N05AF | Flupentixol · Tiotixene · Zuclopenthixol | 25 | 8 |
| N05AA | Chlorpromazine · Levomepromazine · Promazine | 51 | 8 |
| N05AN | Lithium | 26 | 7 |
| N05AC | Mesoridazine · Periciazine · Pipotiazine · Thioridazine | 32 | 3 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is PMS-OLANZAPINE ODT called?
The same molecule, Olanzapine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| OLANZAPIN VIATRIS | Latin | Czechia |
| Zyprexa | Latin | Australia, Bahrain, Czechia, Morocco |
| EGOLANZA | Latin | Czechia |
| OLANZAPIN TEVA | Latin | Czechia |
| APO-Olanzapine ODT | Latin | Australia, Bahrain |
| MARVIL | Latin | Morocco |
| OLANZAPIN ACTAVIS | Latin | Czechia |
| OLANZAPIN MYLAN | Latin | Czechia |
| ZALASTA | Latin | Czechia |
| OLAZINE | Latin | Bahrain |
| ZYPREXA VELOTAB | Latin | Bahrain, Czechia |
| APO-OLANZAPINE | Latin | Australia |
| Olanzapine RBX | Latin | Australia |
| Olanzapine Sandoz | Latin | Australia |
| OLPINAT | Latin | Czechia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.